Computational modeling of transforming growth factor ß and activin a receptor complex formation in the context of promiscuous signaling regulation.
J Biomol Struct Dyn
; 39(14): 5166-5181, 2021 09.
Article
em En
| MEDLINE
| ID: mdl-32597324
ABSTRACT
The Transforming growth factor-beta (TGFß) superfamily is a group of multipotent growth factors that control proliferation, quiescence and differentiation. Aberrant signal transduction and downstream target activation contribute to tumorigenesis and targeted therapy has therefore been considered a promising avenue. Using various modeling pipelines, we analyzed the structure-function relationship between ligand and receptor molecules of the TGFß family. We further simulated the molecular docking of Galunisertib, a small molecule inhibitor targeting TGFß signaling in cancer, which is currently undergoing FDA-approved clinical trials. We found that proprotein dimers of Activin isoforms differ at intrachain disulfide bonds, which support prior evidence of varying pro-domain stability and isoform preference. Further, mature proteins possess flexibility around conserved cystine knots to functionally interact with receptors or regulatory molecules in similar but distinct ways to TGFß. We show that all Activin isoforms are capable of assuming a closed- or open-dimer state, revealing structural promiscuity of their open forms for receptor binding. We propose the first structural landscape for Activin receptor complexes containing a type I receptor (ACVR1B), which shares a pre-helix extension with TGFß type I receptor (TGFßR1). Here, we artificially demonstrate that Activin can bind TGFßR1 in a TGFß-like manner and that TGFß1 can form signaling complexes with ACVR1B. Interestingly, Galunisertib was found to form stable inhibitory structures within the homologous kinase domains of both TGFßR1 and ACVR1B, thus halting receptor-promiscuous signaling. Overall, these observations highlight the challenges of specific TGFß cascade targeting in the context of cancer therapies.Communicated by Ramaswamy H. Sarma.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fator de Crescimento Transformador beta
/
Receptores de Ativinas Tipo I
Tipo de estudo:
Prognostic_studies
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article